Back to Search
Start Over
Nonsteroidal anti-inflammatory drugs (NSAIDs) consideration by dermatologists during the COVID19 pandemic
- Source :
- Journal of Dermatological Treatment, Vol 33, Iss 2, Pp 1134-1135 (2022)
- Publication Year :
- 2022
- Publisher :
- Taylor & Francis Group, 2022.
-
Abstract
- Nonsteroidal anti-inflammatory drugs (NSAIDs) have been an important therapy in the treatment of a large number of cutaneous pathologies for more than three decades. Concerns have been raised that NSAIDs may be associated with an increased risk of adverse effects when used in patients with acute viral respiratory infections. Given the current SARS-CoV-2 (COVID-19) pandemic, the availability of reliable information for clinicians and patients is of extreme importance Although accumulating evidence support the existence of a harmful effect of NSAIDs in some infectious settings, no clinical studies demonstrating that such risk applies in case of COVID-19. Pending further research, a pragmatic and cautionary approach would be to avoid regular NSAID use or as first line option in suspicion of COVID19 symptoms.
- Subjects :
- nsaid
covid19
sars-cov-2
Dermatology
RL1-803
Subjects
Details
- Language :
- English
- ISSN :
- 09546634 and 14711753
- Volume :
- 33
- Issue :
- 2
- Database :
- Directory of Open Access Journals
- Journal :
- Journal of Dermatological Treatment
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.1fb6ca0712384d4d98674c7259f689fc
- Document Type :
- article
- Full Text :
- https://doi.org/10.1080/09546634.2020.1800580